Lb Pharmaceuticals LBRX
NASDAQ LBRX
$40.45 -0.55 (-1.34%)
As of: Oct 21, 2026 · 11:41 AM EDT

Lb Pharmaceuticals (LBRX) Capital Expenditures (2024 - 2026)

Updated

Lb Pharmaceuticals' Capital Expenditures was $363,000 in Q2 2026, compared with -$9,000 a year earlier.

Analysis

Lb Pharmaceuticals (LBRX) Capital Expenditures (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Lb Pharmaceuticals' Capital Expenditures was $435,000 through Jun 30, 2026; for FY2025, it came in at $52,000, down 93.2% from FY2024.

  • In earlier years, Capital Expenditures was $769,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 1.32 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 322.00 Mn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 1.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 140.00 Mn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 533.00 Mn
10 Lb Pharmaceuticals 1.22 Bn -82.84 Mn - 363,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 363,000.00
Mar 31, 2026 32,000.00
Dec 31, 2025 40,000.00
Jun 30, 2025 -9,000.00
Mar 31, 2025 21,000.00
Dec 31, 2024 1.40 Mn
API Access

Lb Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=LBRX&period=max&api_key=YOUR_API_KEY